Cigna Group (CI)

In the past six months, The Cigna Group's stock price was $326.31 as of June 27, 2025, with an 18.2% increase. The 52-week high was $370.83 on September 16, 2024, and the 52-week low was $262.03 on December 17, 2024. Events impacting the stock include strong financial results reported in February and May 2024, the appointment of Michael J. Hennigan to the Board of Directors in June 2025, and RBC Capital reiterating an "Outperform" rating for Cigna. Recent news also includes AI healthcare funding surges and Cigna Healthcare unveiling AI-powered digital tools.

The Cigna Healthcare segment experiences demand seasonality related to stop loss seasonality, resulting in a sequential decrease in net medical costs payable consistent with prior years.

The Cigna Group is a global health service company operating primarily in the healthcare and insurance industry. It operates through two main segments: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services offers coordinated and point solution health services, including pharmacy benefits and care delivery. Cigna Healthcare provides medical, pharmacy, and behavioral health products and services, including health insurance and Medicare plans.

The Cigna Group has a significant global presence, operating in more than 30 countries and jurisdictions. Headquartered in Bloomfield, Connecticut, it has global health benefits operations in Visalia, California; Greenock, Scotland; Shanghai, China; and Antwerp, Belgium. Sales offices are located across North America, Europe, Asia, and the Middle East, serving approximately 165 million customer relationships worldwide.

The Cigna Group has received positive recognition for its corporate citizenship, ranking #6 in America by JUST Capital and CNBC in February 2024. Cigna's Chief Marketing Officer, Lou Aversano, was recognized as ANA's Best B2B Marketer of the Year in March 2025 for a successful campaign. However, the company has faced controversies, including allegations of automatic denials of insurance claims.

The Cigna Group is predominantly owned by institutional shareholders, who hold 88.70% of the company. Individual Cigna Group insiders own 1.65%, and retail investors hold 9.65%. Vanguard Group Inc. is the largest individual shareholder, owning 9.79% of the company. The top 14 shareholders collectively hold 50% of the business.